Jpmorgan Chase & CO Metlife Inc Transaction History

Jpmorgan Chase & CO

$1.23 Trillion
Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Metlife Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 13,122,970 shares of MET stock, worth $1.08 Billion. This represents 0.09% of its overall portfolio holdings.

Number of Shares

13,122,970

Previous 19,941,801 34.19%

Holding current value

$1.08 Billion

Previous $1.64 Billion 34.67%

% of portfolio

0.09%

Previous 0.13%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$78.15 - $88.25 $533 Million - $602 Million	-6,818,831 Reduced 34.19%	13,122,970 $1.07 Billion
Q3 2024 Dec 26, 2024	SELL	$67.96 - $82.48 $81.3 Million - $98.7 Million	-1,196,746 Reduced 5.66%	19,941,801 $1.64 Billion
Q3 2024 Nov 08, 2024	SELL	$67.96 - $82.48 $81.3 Million - $98.7 Million	-1,196,746 Reduced 5.66%	19,941,801 $1.64 Billion
Q2 2024 Dec 26, 2024	BUY	$68.55 - $74.22 $82 Million - $88.8 Million	1,196,746 Added 6.0%	21,138,547 $1.48 Billion
Q2 2024 Aug 12, 2024	BUY	$68.55 - $74.22 $59 Million - $63.8 Million	860,009 Added 4.24%	21,138,547 $1.48 Billion
Q1 2024 Dec 26, 2024	BUY	$65.35 - $74.11 $22 Million - $25 Million	336,737 Added 1.69%	20,278,538 $1.5 Billion
Q1 2024 May 10, 2024	BUY	$65.35 - $74.11 $224 Million - $254 Million	3,422,487 Added 20.3%	20,278,538 $1.5 Billion
Q4 2023 Dec 26, 2024	SELL	$58.29 - $66.9 $180 Million - $206 Million	-3,085,750 Reduced 15.47%	16,856,051 $1.11 Billion
Q4 2023 Feb 12, 2024	BUY	$58.29 - $66.9 $116 Million - $133 Million	1,989,438 Added 13.38%	16,856,051 $1.11 Billion
Q3 2023 Nov 14, 2023	BUY	$56.71 - $66.36 $33.2 Million - $38.9 Million	585,916 Added 4.1%	14,866,613 $935 Million
Q2 2023 Aug 11, 2023	BUY	$49.12 - $61.81 $85.3 Million - $107 Million	1,737,444 Added 13.85%	14,280,697 $807 Million
Q1 2023 May 18, 2023	BUY	$54.3 - $73.58 $16.8 Million - $22.8 Million	310,179 Added 2.54%	12,543,253 $727 Million
Q1 2023 May 11, 2023	SELL	$54.3 - $73.58 $30 Million - $40.6 Million	-552,180 Reduced 4.32%	12,233,074 $709 Million
Q4 2022 Feb 13, 2023	BUY	$62.62 - $76.95 $25.6 Million - $31.4 Million	408,227 Added 3.3%	12,785,254 $925 Million
Q3 2022 Nov 14, 2022	SELL	$22.01 - $68.52 $2.88 Million - $8.95 Million	-130,656 Reduced 1.04%	12,377,027 $752 Million
Q2 2022 Aug 11, 2022	SELL	$60.87 - $72.44 $20.3 Million - $24.2 Million	-333,490 Reduced 2.6%	12,507,683 $785 Million
Q1 2022 May 11, 2022	BUY	$61.96 - $71.63 $59.4 Million - $68.6 Million	958,010 Added 8.06%	12,841,173 $902 Million
Q4 2021 Feb 10, 2022	BUY	$57.11 - $66.6 $19.8 Million - $23.1 Million	347,466 Added 3.01%	11,883,163 $743 Million
Q3 2021 Nov 12, 2021	BUY	$55.86 - $63.61 $644 Million - $734 Million	11,535,697 New	11,535,697 $712 Million

Others Institutions Holding MET

# of Institutions

1,535

Shares Held

488M

Call Options Held

7.28M

Put Options Held

10.2M

View Full List

About METLIFE INC

Ticker MET
Exchange NYSE
Sector Financial Services
Industry Insurance—Life
Shares Outstandng 797,614,016
Market Cap $65.7B
Description
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disabilit...

More about MET

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Metlife Inc Transaction History